|
Catalogusnummer
|
Chemische naam
|
EG-nr.
|
CAS-nr.
|
Indeling
|
Etikettering
|
Specifieke concentratiegrenzen, M-factoren en ATE’s
|
Opmerkingen
|
|
Gevarenklasse en -categorie
|
Gevarenaanduiding
|
Pictogram, signaalwoord
|
Gevarenaanduiding
|
Aanvullende gevarenaanduiding
|
|
“005-007-00-2
|
boorzuur [1]
boorzuur [2]
|
233-139-2 [1]
234-343-4 [2]
|
10043-35-3 [1]
11113-50-1 [2]
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD”
|
|
|
|
|
“005-008-00-8
|
diboortrioxide
|
215-125-8
|
1303-86-2
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD”
|
|
|
|
|
“005-011-00-4
|
tetraboordinatriumheptaoxide, hydraat; [1]
dinatriumtetraboraat, watervrij; [2]
orthoboorzuur, natriumzout [3]
dinatriumtetraboraat-decahydraat [4]
dinatriumtetraboraat-pentahydraat [5]
|
235-541-3 [1]
215-540-4 [2]
237-560-2 [3]
215-540-4 [4]
215-540-4 [5]
|
12267-73-1 [1]
1330-43-4 [2]
13840-56-7 [3]
1303-96-4 [4]
12179-04-3 [5]
|
Repr. 1B
|
H360FD
|
GHS08
Dgr
|
H360FD”
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
“006-069-00-3
|
thiofanaat-methyl (ISO);
dimethyl(1,2-fenyleendicarbamothioyl)biscarbamaat;
dimethyl 4,4′-(o-fenyleen)bis(3-thioallofanaat)
|
245-740-7
|
23564-05-8
|
Carc. 2
Muta. 2
Acute Tox. 4
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H341
H332
H317
H400
H410
|
GHS08
GHS07
GHS09
Wng
|
H351
H341
H332
H317
H410
|
|
inademing: ATE = 1,7 mg/l
(stofdeeltjes en nevels)
M = 10
M = 10”
|
|
|
“006-076-00-1
|
mancozeb (ISO); mangaanethyleenbis(dithiocarbamaat)(polymeer)complex met zinkzout
|
—
|
8018-01-7
|
Carc. 2
Repr. 1B
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H351
H360D
H373 (schildklier, zenuwstelsel)
H317
H400
H410
|
GHS08
GHS07
GHS09
Dgr
|
H351
H360D
H373 (schildklier, zenuwstelsel)
H317
H410
|
|
M = 10
M = 10”
|
|
|
“015-113-00-0
|
tolclofos-methyl (ISO);
O-(2,6-dichloor-p-tolyl) O,O-dimethylthiofosfaat
|
260-515-3
|
57018-04-9
|
Skin Sens. 1B
Aquatic Acute 1
Aquatic Chronic 1
|
H317
H400
H410
|
GHS07
GHS09
Wng
|
H317
H410
|
|
M = 1
M = 1”
|
|
|
“028-007-00-4
|
trinikkeldisulfide;
nikkelsubsulfide; [1]
heazlewoodiet [2]
|
234-829-6 [1]
— [2]
|
12035-72-2 [1]
12035-71-1 [2]
|
Carc. 1A
Muta. 2
Acute Tox. 3
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H350i
H341
H331
H372**
H317
H400
H410
|
GHS08
GHS06
GHS09
Dgr
|
H350i
H341
H331
H372**
H317
H410
|
|
inademing:
ATE = 0,92 mg/l
(stofdeeltjes of nevels)”
|
|
|
“029-002-00-X
|
dikoperoxide;
koper(I)oxide
|
215-270-7
|
1317-39-1
|
Acute Tox. 4
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H332
H302
H318
H410
|
|
inademing: ATE = 3,34 mg/l (stofdeeltjes of nevels)
oraal: ATE = 500 mg/kg lichaamsgewicht
M = 100
M = 10”
|
|
|
“029-015-00-0
|
koperthiocyanaat
|
214-183-1
|
1111-67-7
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
EUH032
|
M = 10
M = 10”
|
|
|
“029-016-00-6
|
koper(II)oxide
|
215-269-1
|
1317-38-0
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 100
M = 10”
|
|
|
“029-017-00-1
|
dikoperchloridetrihydroxide
|
215-572-9
|
1332-65-6
|
Acute Tox. 4
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H301
H400
H410
|
GHS06
GHS09
Dgr
|
H332
H301
H410
|
|
inademing: ATE = 2,83 mg/l (stofdeeltjes of nevels)
oraal: ATE = 299 mg/kg lichaamsgewicht
M = 10
M = 10”
|
|
|
“029-018-00-7
|
tetrakoperhexahydroxidesulfaat; [1]
tetrakoperhexahydroxidesulfaathydraat [2]
|
215-582-3 [1]
215-582-3 [2]
|
1333-22-8 [1]
12527-76-3 [2]
|
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H400
H410
|
GHS07
GHS09
Wng
|
H302
H410
|
|
oraal: ATE = 500 mg/kg lichaamsgewicht
M = 10
M = 10”
|
|
|
“029-019-01-X
|
koperschilfers (gecoat met alifatisch zuur)
|
—
|
—
|
Acute Tox. 3
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H331
H302
H319
H400
H410
|
GHS06
GHS09
Dgr
|
H331
H302
H319
H410
|
|
inademing: ATE = 0,733 mg/l (stofdeeltjes of nevels)
oraal: ATE = 500 mg/kg lichaamsgewicht
M = 10
M = 10”
|
|
|
“029-020-00-8
|
koper(II)carbonaat--koper(II)hydroxide (1:1)
|
235-113-6
|
12069-69-1
|
Acute Tox. 4
Acute Tox. 4
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H319
H400
H410
|
GHS07
GHS09
Wng
|
H332
H302
H319
H410
|
|
inademing: ATE = 1,2 mg/l (stofdeeltjes of nevels)
oraal: ATE = 500 mg/kg lichaamsgewicht
M = 10
M = 10”
|
|
|
“029-021-00-3
|
koperdihydroxide;
koper(II)hydroxide
|
243-815-9
|
20427-59-2
|
Acute Tox. 2
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H330
H302
H318
H400
H410
|
GHS06
GHS05
GHS09
Dgr
|
H330
H302
H318
H410
|
|
inademing: ATE = 0,47 mg/l (stofdeeltjes of nevels)
oraal: ATE = 500 mg/kg lichaamsgewicht
M = 10
M = 10”
|
|
|
“029-022-00-9
|
Bordeauxse pap;
reactieproducten van kopersulfaat met calciumdihydroxide
|
—
|
8011-63-0
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H332
H318
H410
|
|
inademing: ATE = 1,97 mg/l (stofdeeltjes of nevels)
M = 10
M = 1”
|
|
|
“029-023-00-4
|
kopersulfaat-pentahydraat
|
231-847-6
|
7758-99-8
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H302
H318
H410
|
|
oraal: ATE = 481 mg/kg lichaamsgewicht
M = 10
M = 1”
|
|
|
“601-029-00-7
|
dipenteen;
limoneen [1]
(S)-p-mentha-1,8-dieen; l-limoneen [2]
trans-1-methyl-4-(1-methylvinyl)cyclohexeen; [3]
(±)-1-methyl-4-(1-methylvinyl)cyclohexeen [4]
|
205-341-0 [1]
227-815-6 [2]
229-977-3 [3]
231-732-0 [4]
|
138-86-3 [1]
5989-54-8 [2]
6876-12-6 [3]
7705-14-8 [4]
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H226
H315
H317
H400
H410
|
GHS02
GHS07
GHS09
Wng
|
H226
H315
H317
H410
|
|
|
C”
|
|
“601-096-00-2
|
(R)-p-mentha-1,8-dieen;
d-limoneen
|
227-813-5
|
5989-27-5
|
Flam. Liq. 3
Skin Irrit. 2
Skin Sens. 1B
Asp. Tox. 1
Aquatic Acute 1
Aquatic Chronic 3
|
H226
H315
H317
H304
H400
H412
|
GHS02
GHS07
GHS08
GHS09
Dgr
|
H226
H315
H317
H304
H410
|
|
M = 1”
|
|
|
“603-024-00-5
|
1,4-dioxaan
|
204-661-8
|
123-91-1
|
Flam. Liq. 2
Carc. 1B
STOT SE 3
Eye Irrit. 2
|
H225
H350
H335
H319
|
GHS02
GHS08
GHS07
Dgr
|
H225
H350
H335
H319
|
EUH019
EUH066
|
|
D”
|
|
“603-066-00-4
|
7-oxa-3-oxiranylbicyclo[4.1.0]heptaan; 1,2-epoxy-4-epoxyethylcyclohexaan; 4-vinylcyclohexeendiëpoxide
|
203-437-7
|
106-87-6
|
Carc. 1B
Muta. 2
Repr. 1B
Acute Tox. 3
Acute Tox. 4
|
H350
H341
H360F
H331
H302
|
GHS08
GHS06
Dgr
|
H350
H341
H360F
H331
H302
|
|
inademing: ATE = 0,5 mg/l (stofdeeltjes of nevels)
oraal: ATE = 1 847 mg/kg lichaamsgewicht”
|
|
|
“603-098-00-9
|
2-fenoxyethanol
|
204-589-7
|
122-99-6
|
Acute Tox. 4
STOT SE 3
Eye Dam. 1
|
H302
H335
H318
|
GHS05
GHS07
Dgr
|
H302
H335
H318
|
|
oraal:
ATE = 1 394 mg/kg lichaamsgewicht”
|
|
|
“606-004-00-4
|
4-methylpentaan-2-on; isobutylmethylketone
|
203-550-1
|
108-10-1
|
Flam. Liq. 2
Carc. 2
Acute Tox. 4
STOT SE 3
Eye Irrit. 2
|
H225
H351
H332
H336
H319
|
GHS02
GHS07
GHS08
Dgr
|
H225
H351
H332
H336
H319
|
EUH066
|
inademing: ATE = 11 mg/l (dampen)”
|
|
|
“607-421-00-4
|
cypermethrin (ISO);
α-cyaan-3-fenoxybenzyl 3-(2,2-dichloorvinyl)-2,2-dimethylcyclopropaan-carboxylaat; cypermethrin cis/trans +/- 40/60
|
257-842-9
|
52315-07-8
|
Acute Tox. 4
Acute Tox. 4
STOT SE 3
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H332
H302
H335
H373 (zenuwstelsel)
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H332
H302
H335
H373 (zenuwstelsel)
H410
|
|
oraal; ATE = 500 mg/kg lichaamsgewicht
inademing; ATE = 3,3 mg/l (stofdeeltjes of nevels)
M = 100000
M = 100000”
|
|
|
“607-424-00-0
|
trifloxystrobin (ISO); methyl(E)-methoxyimino-{(E)-α-[1-(α,α,α-trifluor-m-tolyl)ethylidwenaminooxy]-o-tolyl}acetaat
|
—
|
141517-21-7
|
Lact.
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H362
H317
H400
H410
|
GHS07
GHS09
Wng
|
H362
H317
H410
|
|
M = 100
M = 10”
|
|
|
“607-434-00-5
|
mecoprop-P (ISO) [1] en zouten daarvan;
(R)-2-(4-chloor-2-methylfenoxy)propionzuur [1] en zouten daarvan
|
240-539-0 [1]
|
16484-77-8 [1]
|
Acute Tox. 4
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H302
H318
H400
H410
|
GHS07
GHS05
GHS09
Dgr
|
H302
H318
H410
|
|
oraal: ATE = 431 mg/kg lichaamsgewicht
M = 10
M = 10”
|
|
|
“608-058-00-4
|
esfenvaleraat (ISO);
(S)-α-cyaan-3-fenoxybenzyl-(S)-2-(4-chloorfenyl)-3-methylbutyraat
|
—
|
66230-04-4
|
Acute Tox. 3
Acute Tox. 3
STOT SE 1
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H331
H301
H370 (zenuwstelsel)
H373
H317
H400
H410
|
GHS06
GHS08
GHS09
Dgr
|
H331
H301
H370 (zenuwstelsel)
H373
H317
H410
|
|
oraal; ATE = 88,5 mg/kg lichaamsgewicht
inademing; ATE = 0,53 mg/l (stofdeeltjes of nevels)
M = 10 000
M = 10 000 ”
|
|
|
“612-067-00-9
|
3-aminomethyl-3,5,5-trimethylcyclohexylamine
|
220-666-8
|
2855-13-2
|
Acute Tox. 4
Skin Corr. 1B
Eye Dam. 1
Skin Sens. 1A
|
H302
H314
H318
H317
|
GHS05
GHS07
Dgr
|
H302
H314
H317
|
|
oraal: ATE = 1 030 mg/kg lichaamsgewicht
Skin Sens. 1A; H317: C ≥ 0,001 %”
|
|
|
“612-252-00-4
|
imidacloprid (ISO);
(E)-1-(6-chloor-3-pyridylmethyl)-N-nitroimidazolidine-2-ylideenamine;
(2E)-1-[(6-chloorpyridine-3-yl) methyl]-N-nitroimidazolidine-2-imine
|
428-040-8
|
138261-41-3
|
Acute Tox. 3
Aquatic Acute 1
Aquatic Chronic 1
|
H301
H400
H410
|
GHS06
GHS09
Dgr
|
H301
H410
|
|
oraal: ATE = 131 mg/kg lichaamsgewicht
M = 100
M = 1 000 ”
|
|
|
“613-048-00-8
|
carbendazim (ISO); methylbenzimidazool-2-ylcarbamaat
|
234-232-0
|
10605-21-7
|
Muta. 1B
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
|
H340
H360FD
H317
H400
H410
|
GHS07
GHS08
GHS09
Dgr
|
H340
H360FD
H317
H410
|
|
M = 10
M = 10”
|
|
|
“613-102-00-0
|
dimethomorf (ISO); (E,Z)-4-(3-(4-chloorfenyl)-3-(3,4-dimethoxyfenyl)acryloyl)morfoline
|
404-200-2
|
110488-70-5
|
Repr. 1B
Aquatic Chronic 2
|
H360F
H411
|
GHS08
GHS09
Dgr
|
H360F
H411”
|
|
|
|
|
“613-111-00-X
|
1,2,4-triazool
|
206-022-9
|
288-88-0
|
Repr. 1B
Acute Tox. 4
Eye Irrit. 2
|
H360FD
H302
H319
|
GHS08
GHS07
Dgr
|
H360FD
H302
H319
|
|
oraal: ATE = 1 320 mg/kg lichaamsgewicht”
|
|
|
“613-166-00-X
|
flumioxazin (ISO);
N-(7-fluor-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazine-6-yl)cyclohex-1-een-1,2-dicarboximide
|
—
|
103361-09-7
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 1 000
M = 1 000 ”
|
|
|
“613-208-00-7
|
imazamox (ISO);
(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazoline-2-yl)-5-methoxymethylnicotinezuur
|
—
|
114311-32-9
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 10
M = 10”
|
|
|
“613-267-00-9
|
thiamethoxam (ISO);
3-(2-chloor-thiazool-5-ylmethyl)-5-methyl[1,3,5]oxadiazinaan-4-ylideen-N-nitroamine
|
428-650-4
|
153719-23-4
|
Repr. 2
Acute Tox. 4
Aquatic Acute 1
Aquatic Chronic 1
|
H361fd
H302
H400
H410
|
GHS07
GHS08
GHS09
Wng
|
H361fd
H302
H410
|
|
oraal: ATE = 780 mg/kg lichaamsgewicht
M = 10
M = 10”
|
|
|
“613-282-00-0
|
triticonazool (ISO);
(RS)-(E)-5-(4-chloorbenzylideen)-2,2-dimethyl-1-(1H-1,2,4-triazool-1-methyl)cyclopentanol
|
—
|
138182-18-0
|
Repr. 2
STOT RE 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361f
H373
H400
H410
|
GHS08
GHS09
Wng
|
H361f
H373
H410
|
|
M = 1
M = 1”
|
|
|
“616-032-00-9
|
diflufenican (ISO);
N-(2,4-difluorfenyl)-2-[3-(trifluormethyl)fenoxy]-3-pyridinecarboxamide; 2′,4′-difluor-2-(α,α,α-trifluor-m-tolyloxy)nicotinanilide
|
—
|
83164-33-4
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 10 000
M = 1 000 ”
|
|
|
“616-106-00-0
|
fenmedifam (ISO); methyl 3-(3-methylcarbaniloyloxy)carbanilaat
|
237-199-0
|
13684-63-4
|
Aquatic Acute 1
Aquatic Chronic 1
|
H400
H410
|
GHS09
Wng
|
H410
|
|
M = 10
M = 10”
|
|
|
“616-113-00-9
|
desmedifam (ISO);
ethyl-3-fenylcarbamoyloxyfenylcarbamaat
|
237-198-5
|
13684-56-5
|
Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
|
H361d
H400
H410
|
GHS08
GHS09
Wng
|
H361d
H410
|
|
M = 10
M = 10”
|
|